SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ATIS is on the move!
ATIS 0.1000-47.4%Apr 14 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rick Strange who wrote (1865)8/5/1999 11:15:00 PM
From: Marshall Teitelbaum  Read Replies (1) of 2205
 
Rick,

Missing in the current environment is the extremely important long-term fundamental fact that optimization of the cartilage product is apparently complete.......meaning that the clinical trial should start as originally hoped in the 1Q, 2000, without the retrospective analysis possibility that DG went through. Of course ATIS won't have much to say regarding DG at this point, as would be expected, and they are still in a quiet period so can't really say anything anyway. Sounds as if they're still sticking with the thought of being on track to submit to the FDA in the 4Q if statistical analysis for the interim trial is significant.

Regards,

Marshall
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News